Decision Diagnostics Valuation
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Decision Diagnostics from reviewing the firm fundamentals such as Current Valuation of 3.06 M, shares outstanding of 357.87 M, and Operating Margin of (0.95) % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Decision Diagnostics' valuation include:
Price Book 2.7161 | Enterprise Value | Enterprise Value Ebitda (1.49) | Price Sales 0.0168 | Enterprise Value Revenue 1.4379 |
Overvalued
Today
Please note that Decision Diagnostics' price fluctuation is very steady at this time. Calculation of the real value of Decision Diagnostics is based on 3 months time horizon. Increasing Decision Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Decision Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Decision Stock. However, Decision Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Decision Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Decision Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Decision Diagnostics helps investors to forecast how Decision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Decision Diagnostics more accurately as focusing exclusively on Decision Diagnostics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Decision Diagnostics' intrinsic value based on its ongoing forecasts of Decision Diagnostics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Decision Diagnostics' closest peers.
Decision Diagnostics Cash |
|
About Decision Diagnostics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Decision Diagnostics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Decision Diagnostics based exclusively on its fundamental and basic technical indicators. By analyzing Decision Diagnostics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Decision Diagnostics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Decision Diagnostics. We calculate exposure to Decision Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Decision Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 448.6 K | 774.8 K | |
| Pretax Profit Margin | (13.49) | (14.17) | |
| Operating Profit Margin | (0.96) | (1.01) | |
| Net Loss | (13.49) | (14.17) | |
| Gross Profit Margin | 0.23 | 0.18 |
Decision Diagnostics Current Valuation Indicators
Decision Diagnostics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Decision Diagnostics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Decision Diagnostics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Decision Diagnostics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Decision Diagnostics' worth.When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value—what Decision Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.